蒙特卢卡斯特的营销后安全问题:基于FDA不良事件报告系统的药监测研究
概括
蒙特卢卡斯特 (MTK) 与精神疾病有关,特别是在18岁以下的患者中. 这项研究分析了FDA的数据,揭示了与MTK相关的精神病和其他不良事件,突出了精神病副作用的年龄偏好模式.
科学领域:
- 药监和药物安全 药监和药物安全
- 临床药理学 临床药理学
- 不良事件分析不良事件分析
背景情况:
- 美国食品和药物管理局 (FDA) 发布了有关与蒙特卢卡斯特 (MTK) 相关的精神疾病的警告.
- 了解MTK相关不良事件 (AE) 的特征对于患者的安全性和风险-益处评估至关重要.
研究的目的:
- 通过分析与其相关的不良事件 (AEs) 来调查蒙特卢卡斯特 (MTK) 的安全信号.
- 用不成比例分析来描述MTK报告的AE类型和模式.
- 为了确定潜在的未报告的副作用和MTK相关精神疾病的特定年龄趋势.
主要方法:
- 利用FDA不良事件报告系统 (FAERS) 数据库进行数据提取.
- 在2004年1月至2022年12月期间,对27,507个报告的副作用进行了病例 (MTK) 与非病例 (所有其他药物) 的不成比例性分析.
- 分析了AE发生的时间和人口统计数据,重点关注儿科人口中的精神病AE.
主要成果:
- 精神病,呼吸道,胸腔和中关节疾病以及社会情况是与MTK相关的最频繁报告的副作用.
- 确定了几种潜在的未报告的副作用,包括心血压升高,腹功能障碍,甲状腺功能低下,肥胖,囊炎和多囊性卵巢.
- 与MTK相关的AE主要表现为急性影响,其中60.1%的精神病AE报告涉及18岁以下的患者.
结论:
- 蒙特卢卡斯特 (MTK) 与一系列不良事件有关,特别是精神疾病,在儿科患者中具有显著的偏好.
- 研究结果显示,在接受MTK治疗的患者中,精神病学AE的年龄偏好模式,强调需要对年轻人进行仔细监测.
- 这项研究为医疗保健专业人员提供了宝贵的见解,通过更好地评估MTK的风险和好处,从而优化患者护理.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
267
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
267
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
01:19Pharmacovigilance
801
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
801
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
255
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
255
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
243
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
243
01:24Antiasthma Drugs: Methylxanthines
213
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
213